Parenterāli ievadāmo zāļu onkoloģisko saslimšanu ārstēšanai iegāde 2027. un 2028.gadam
Awarded
The competition has ended and a winner has been selected.
- Award
- Price only
- Procedure
- OpenSingle stage
- Agreement
- Framework agreement
Brief
Nacionālais veselības dienests ir noslēdzis pamatlīgumu ar SIA "Oribalt Rīga", Sabiedrība ar ierobežotu atbildību "MAGNUM MEDICAL", Sabiedrība ar ierobežotu atbildību "Tamro", AS "RECIPE PLUS", SIA "UNIFARMA", SIA "SAULES APTIEKA", Sabiedrība ar ierobežotu atbildību "ELVIM" un SIA "Baltacon" par parenterāli ievadāmo zāļu onkoloģisko saslimšanu ārstēšanai piegādi Latvijā 2027. un 2028. gadam.
Farmasøytisk engroshandel
Result
- AS "RECIPE PLUS"Winner
- SIA "Baltacon"Winner
- SIA "Oribalt Rīga"Winner
- SIA "SAULES APTIEKA"Winner
- SIA "UNIFARMA"Winner
- 9Number of bids
- Not statedContract value
- Maximum framework agreement valueUp to €7,060,515
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Zemākā piedāvātā vienas vienības cena EUR (bez PVN) katrā iepirkuma priekšmeta pozīcijā.
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Nacionālais veselības dienests
From the notice
Parenterāli ievadāmo zāļu onkoloģisko saslimšanu ārstēšanai iegāde 2027. un 2028.gadam
Contact
nvd@vmnvd.gov.lv- Result · Framework agreementType
- 33600000Main codePharmaceutical products